The market and curative effect serves as the best acceptance standard concerning ethnic medicine, according to Dou Qiling, a CPPCC member, during an interview on March 4.

Dou Qiling, a CPPCC member, talks about ethnic Miao medicine during the two sessions on March 4. [Photo/chinadaily.com.cn]

The Guizhou provincial government promoted the health and pharmaceutical industry in Beijing, and the abundant resources have attracted enterprises from other provinces to join in the Guizhou health industry competition, Dou said.

“Only advanced management expertise and self-improvement can help boost the development of local enterprises and expand the market,” said Dou.

According to Dou, in the process of developing health industrial distribution, collaboration is the best solution of enterprise scale.

“To expand the enterprise scale, acquisition does not have to happen, the integration of brands with good reputation, which hugely favors the development of local enterprises, should be taken full advantage of,” said Dou, chairman of Yibai Pharmaceutical Co.

Yibai Pharmaceutical Co, as the representative of Miao medicine, has become the first private company listed in 2004.

Yibai, which bears the mission of making Miao medicine prevalent, set up the Miao medicine pharmacy research and study center in 2014 and has achieved breakthroughs in Guizhou traditional Chinese medicine and ethnic Miao medicine.

Yibai will keep promoting research on traditional Chinese medicine and the industrialization and commercialization of ethnic Miao medicine, meanwhile providing ethnic Miao pharmacies with better technical support, said Dou.

The sales revenue of Miao medicine surmounts the sum total of other ethnic medicines in recent years. Guizhou pharmaceutical enterprises should integrate with the big data industry, which helps expand its online market.